Inflammatory biomarkers in patients with sciatica: a systematic review

Abstract

Background This systematic review focusses on inflammation as an underlying pathogenic mechanism in sciatica. We addressed two questions in particular: (1) what inflammatory biomarkers have been identified in patients with sciatica in the literature so far? 2) is there an association between the level of inflammatory activity and clinical symptoms? Methods The search was conducted up to December 19th 2018 in MEDLINE, EMBASE, CENTRAL and Web of Science. The study selection criteria: (1) observational cohort studies, cross-sectional studies and randomized clinical trials (RCT), (2) adult population (≥ 18 years) population with sciatica, (3) concentrations of inflammatory biomarkers measured in serum, cerebrospinal fluid (CSF) or biopsies, and (4) evaluation of clinically relevant outcome measures (pain or functional status). Three reviewers independently selected studies and extracted data regarding the study characteristics and the outcomes. Risk of Bias was evaluated using an adjusted version of the Quality in Prognosis Studies (QUIPS) tool. Results In total 16 articles fulfilled the criteria for inclusion: 7 cross sectional observational studies and 9 prospective cohort studies that included a total of 1212 patients. With regard to question 1) the following markers were identified: interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-17, IL-21, tumor necrosis factor-α (TNF-α), phospholipase A2, high sensitivity C-reactive protein (hsCRP), C-X-C motif chemokine 5 (CXCM5), CX3CL1, CCL2, epidermal growth factor (EGF), and monocyte chemotactic protein 4 (MCP-4). With regard to question 2) several positive correlations were found in longitudinal studies: a strong positive correlation between inflammatory mediators or byproducts and pain (measured by visual analogue scale, VAS) was found for IL-21 in two studies (r > 0,8), and moderate positive correlations for TNF-a in both serum (r = 0,629) and biopsy (r = 0.65); severe pain (VAS > 4) is associated with increased hsCRP levels among patients with sciatica (adjusted OR = 3.4 (95% CI, 1.1 to 10). Conclusion In this systematic review there was considerable heterogeneity in the type of biomarkers and in the clinical measurements in the included studies. Taking into account the overall risk of bias of the included studies there is insufficient evidence to draw firm conclusions regarding the relationship between inflammation and clinical symptoms in patients with sciatica. Electronic supplementary material The online version of this article (10.1186/s12891-019-2541-0) contains supplementary material, which is available to authorized users.

Cerebrospinal fluid and optic nerve sheath compartment syndrome: A common pathophysiological mechanism in five different cases?

“…19 Thus, not only do we postulate that the impaired clearance system of CSF plays a role in the pathogenesis of neurodegenerative diseases, but we also suggest that the ONSCS is often caused by MEC-induced inflammatory changes in the meninges surrounding the ON as well as in the trabeculae and septae in the ON SAS, leading to compartmentation and altered CSF dynamics. 16 Several studies 20,33,34 in dogs and humans with disc herniations demonstrated upregulation of cytokines, among them interleukin (IL)-8, but also IL-6, tumour necrosis factor-alfa and albumin. The mechanisms for these changes include mechanical irritation and cross-talk.…”

Szérumbiomarkerek akut lumbalis-lumbosacralis fájdalomban

“…Mivel a porckorongsérvhez és a gerincoszlop egyéb degeneratív elváltozásaihoz társuló lumbalis-lumbosacralis fájdalom patogenezisében szerepet játszik a gyulladás (1. táblázat) [13][14][15], és feltételezhető, hogy ilyen esetekben egyes gyulladásos mediátorok szintje a vérben mérhetően megemelkedik, a következőkben áttekintjük azon biomarkereket, melyekben változást találtak ebben a betegcsoportban (2. táblázat).…”

“…A lumbalis-lumbosacralis fájdalom kialakulásának komponensei [13][14][15] A károsodás jellege és szintje A fájdalom oka [13].…”

“…Számottevő lehet, hogy az akut stádium esetén mely szérumbiomarkerek szintje emelkedett, és ezeknek van-e prognosztikai értékük például a fájdalom krónikussá válásában. A kutatások célja, hogy a közeljövőben a biomarkerek segítségével megjósolhatóvá váljon a lumbalis-lumbosacralis fájdalom klinikai lefolyása, illetve a betegcsoportok elkülönítése aszerint, hogy a konzervatív vagy a műtéti terápiától várhatunk jobb eredményt a kezelés során [14].…”

Insights into the inflammatory process of lumbar discopathy

“…Twenty years later, a recent systematic review has found it difficult to "draw firm conclusions regarding the relationship between inflammation and clinical symptoms with sciatica" [2].…”